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Abstract
Purpose: Intensity modulated radiotherapy (IMRT) in the recent past has established itself as a gold standard for organs at risk
(OAR) sparing, target coverage and dose conformity. With the advent of a rotational treatment technology such as volumetric
modulated arc therapy (VMAT), an inter-comparison is warranted to address the advantages and disadvantages of each tech-
nique. Methods: Twenty patients were selected retrospectively from our patient database. Sites included were brain, head and
neck, chest wall, and prostate, with five patients for each site. For all the selected patients, both the IMRT and VMAT treatment
plans were generated. Plan comparison was done in terms of OAR dose, dose homogeneity index (HI), dose conformity index
(CI), target coverage, low isodose volumes, monitor units (MUs), and treatment time. Results: The VMAT showed better sparing
of “parotids minus planning target volume (PTV)”, spinal cord and head of femur as compared to the IMRT. The lung V40 for
VMAT was lower, whereas the lung V10, contralateral lung mean dose, contralateral breast mean dose and mean body dose were
lower with IMRT for chest wall cases. Both the VMAT and IMRT achieved comparable HI except for the brain site, where
IMRT scored over VMAT. The CI achieved by the IMRT and VMAT were similar except for chest wall cases, whereas the
VMAT achieved better dose conformity. The target coverage was comparable with both the plans. The VMAT clearly scored
over IMRT in terms of average MUs (486 versus 812 respectively) and average treatment time (2.54 minutes versus 5.54
minutes) per treatment session. Conclusion: The VMAT (RapidArc) has a potential to generate treatment plans for various ana-
tomical sites which are comparable with the corresponding IMRT plans in terms of OAR sparing and plan quality parameters.
The VMAT significantly reduces treatment time as compared to the IMRT, thus VMAT can increase the throughput of a busy
radiotherapy department.
Keywords:VMAT; RapidArc; IMRT; Plan Comparison
Introduction
The very basic aim of radiotherapy is to deliver a tumoricidal
dose to the target and at the same time spare the normal
structures in the vicinity. To achieve this goal, technology is
driving radiotherapy in future and that is how we have
moved from three dimensional conformal radiotherapy
(3D-CRT) to intensity modulated radiotherapy (IMRT) and
volumetric modulated arc therapy (VMAT). IMRT in the
recent past has established itself as a gold standard for organs
at risk (OAR) sparing, target coverage and dose conformity.
With the advent of VMAT (Rapid Arc), an inter-comparison
is needed to address the advantages and disadvantages of each
technique.
IMRT uses multi-leaf collimator (MLC) modulated beam
delivery planned with inverse treatment planning system
(TPS). IMRT treatments can be delivered by two methods.
The first technique is called “Step and Shoot IMRT” in which,
gantry is static at a specific angle and MLCs are static in a
specific position when the beam is turned on. The second
technique is called “Dynamic IMRT” in which the gantry is
static at a specific angle and MLCs continuously change their
positions when the beam is turned on. The classical approach
to IMRT planning involves optimization of fluence maps
followed by an MLC leaf sequencing step. Several investiga-
tors have proposed directly optimizing leaf positions and
segment weights.1, 2 In the recent past, a new technology in
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radiotherapy called Rapid Arc - a type of VMAT technique
has emerged. VMAT dose optimization employs aperture
based method that incorporates MLC leaf positions and MU
weights as optimization parameters. VMAT is a rotational
radiotherapy modality with dynamic MLC and varying dose
rate. VMAT planning process optimises gantry rotation speed,
dose rate, and MLC positions to create a plan. It delivers
radiation with multiple superimposing coplanar or
non-coplanar arcs. Hence, during the delivery of a VMAT
plan, gantry continuously rotates, dose rate keeps changing
and MLCs continuously move when the beam is on.
We performed a comparison of VMAT (RapidArc) treatment
plans with IMRT plans in terms of OAR doses and various
dose parameters which reflect the quality and delivery effi-
ciency of a plan. Various studies have shown that VMAT may
provide plan improvements for cervix and intracranial tu-
mors.3, 4, 5, 6 Several authors have also compared VMAT with
tomotherapy.7, 8, 9 Alvarez-Moret et al.10 evaluated VMAT
with Oncentra Master Plan and compared with IMRT for
the treatment of head and neck cancer.
A multi-institutional comparison of VMAT vs. IMRT for
head-and-neck cancer showed superior VMAT plan quality
parameters.11 Stieler et al.12 compared IMRT with VMAT in
head and neck cancers and validated the dosimetric accuracy
of VMAT. Johnston et al.13 compared simultaneous integrated
boost plans generated with IMRT and VMAT for head and
neck cancers and concluded that VMAT achieves comparable
plans to IMRT and uses two-thirds less monitor units. Palma
et al.14 compared VMAT with IMRT for prostate cancer and
found more favourable dose distributions with VMAT. Quan
et al.15 reported superior plan quality as well as delivery effi-
ciency of VMAT in prostate cancer. Zhang et al.16 showed
that VMAT reduces beam on time by up to 55% as compared
to five-field IMRT for prostate cancer. Rao et al.17 compared
VMAT with IMRT for prostate, head-neck, and lung cancer
cases. They reported 40% reduction in treatment time with
VMAT while maintaining the plan quality for all the sites
studied. Ali et al.18 have compared VMAT with IMRT for
pancreatic cancer and Rana et al.19 have compared proton
therapy with VMAT and IMRT for lung cancer. Oliver et al.20
have studied Rapid Arc and IMRT on virtual phantoms.
For the present study, sites which were considered for plan
comparison include brain, head and neck, chest wall, and
prostate malignancies. These cases were selected to represent
a large range of clinical and anatomical complexity. The
primary aim of this study is to compare the plan quality and
treatment efficiency parameters of IMRT and VMAT (Rapid
Arc) for different anatomical sites in order to weigh the ben-
efits and drawbacks of each of these two high precision radi-
otherapy techniques.
Methods and Materials
A total of 20 patients including brain, head and neck, chest
wall and prostate malignancies were selected with five pa-
tients of each anatomical site. Both VMAT and IMRT plans
were generated for each patient based on identical anatomic
contours, dose prescriptions and planning objectives.
Anatomical site brain included World Health Organization
(WHO) grade III and IV glioma (post-surgery). Head and
neck site included base of tongue and hypo-pharyngeal ma-
lignancies. Chest wall site included post-mastectomy patients
requiring adjuvant radiation therapy. Pelvis site included
high risk prostate cancer patients requiring radiation therapy
to prostate, seminal vesicles and pelvic nodes. Table 1
demonstrates the dose prescription used for treatment plan-
ning.
TABLE 1: Radiation dose prescription for four different anatomical sites.
S. No Site Target Dose prescribed(cGy)
Dose per fraction
(cGy)
Number of
fractions
1 Brain(Sequential boost)
PTV 1 (Phase 1) 4500 180 25
PTV 2 (Phase 2) 1440 180 8
2 Head and Neck(simultaneousintegrated boost)
PTV-66 6600 200
33PTV-59.4 5940 180
PTV-54 5400 163.6
3 Chest wall PTV-50 5000 200 25
4 Prostate (Sequential boost)
PTV 1 (Phase 1) 5000 200 25
PTV 2 (Phase 2) 600 200 3
PTV 3 (Phase 3) 2200 200 11
Abbreviation: PTV = planning target volume
All the patients were immobilized in orfit thermoplastic cast
(orfit with vacloc for chest wall and prostate cases). Planning
CT scan was done using Siemens dual source 64 slice com-
puted tomography (CT) simulator (Siemens Medical Solu-
tions, Malvern, PA, United States) and 3.0 mm CT slices were
obtained. CT images were imported in DICOM format to
Eclipse TPS, version 8.9 (Varian Medical Systems, Palo Alto,
CA, United States). Target volumes and OARs were con-
toured. For each patient, both the IMRT and VMAT treat-
ment planning was done using Eclipse TPS (version 8.9) and
plans were computed using Anisotropic Analytic Algorithm
(AAA) dose calculation algorithm. The grid size utilized for 
dose calculation was 0.25 cm.
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Multiple planners were involved in plan generation. During
the process of plan optimization, planners adjusted the dose
volume constraints in order to respect the OAR dose toler-
ance. Table 2 shows the dose volume constraints of OAR
utilised for treatment planning. Table 3 shows beam geome-
try of IMRT and VMAT (Rapid Arc) plans for the four sites.
All the VMAT (Rapid Arc) plans were performed with 2
coplanar arcs. Vieillot et al.21 compared double arc with single
arc VMAT (Rapid Arc) in anal canal cancer and found that
double arc plans resulted in superior target coverage, dose
homogeneity and conformity. Similar comparison study be-
tween single and double arc Rapid Arc plans was done by
Kumar et al.22 for head and neck cancers.
TABLE 2: Dose volume constraints utilised for radiotherapy
planning.
S. No. Organ at Risk(OAR)
Dose maxi-
mum (cGy) Volume
Dose
(cGy)
1 Bain Stem23 <5400 1-10 cc <5900
2 Lens24 <700 - -
3 Retina24 <4500 - -
4 Optic nerve23 <5500 - -
5 Optic chiasm23 <5500 - -
6 Parotid23 - Mean <2500
7 Spinal cord24 <4500 - -
8 Cochlea23 - Mean <4500
9 Ipsilateral lung - <20% 2000
10 Heart23 - Mean <2600
11 Contralateralbreast - Mean <300
12 Rectum23, 24 - <20%<35%
7000
6500
13 Bladder23 - <35%<50%
7000
6500
14 Femoral head24 - <5% 5000
15 Bowel24 - <100 cc 4000
TABLE 3: Geometry of treatment fields/arcs.
Site IMRT field geometry VMAT (Rapid Arc) trajecto-ry
Brain 5 fields, coplanar. 2 coplanar arcs with360 degree arc trajectory.
Head and
Neck 7 fields, coplanar.
2 coplanar arcs with
360 degree arc trajectory.
Breast
2 Tangents with mul-
tiple sub-fields (field in
field)
2 coplanar partial arcs with
arc trajectory:
a) 225 degree to 45 degree
clock wise and 45 degree
to 225 degree counter
clock wise for right chest
wall.
b) 315 degree to 135 degree
clock wise and 135 de-
gree to 315 degree coun-
ter clock wise for left
chest wall.
Prostate 7 fields, coplanar. 2 coplanar arcs with360 degree arc trajectory.
For chest wall patients, forward IMRT (field in field tech-
nique) planning was done. For cases with multiple targets,
either sequential boost or simultaneous integrated boost (SIB)
scheme of dose prescription was utilised. VMAT planning
optimization algorithm is based on Progressive Resolution
Optimizer (PRO) which uses direct aperture optimization.
Because of physical limitations, upper limits were imposed on
MLC leaf motion (2.5 cm/sec), dose rate (600 MU/min) and
gantry speed (5.5 degree/sec) to ensure deliverability. The
linear accelerator used to deliver IMRT and VMAT plans was
Varian Clinac 2100 iX (Varian Medical Systems, Palo Alto,
CA, United States). Both the IMRT and VMAT plans were
normalized such that at least 95% of target volume received at
least 95% of prescription dose. Site specific plan comparison
was performed between IMRT and VMAT plans.
Plan comparison parameters
1) OAR Dose: Mean doses were used for parallel
structures and maximum doses were used for serial
structures. Additional dose parameters used for plan
comparison were: V10, V20 and V40 (percentage
volume of organ receiving respective dose in Gy) for
lung and heart, V70, V65 and V40 for rectum and
urinary bladder, V50 for head of femur and V40 for
bowel.
2) Dose Homogeneity Index: IMAX/IR, where IMAX is the
maximum isodose inside the target volume and IR is
the reference isodose (95% isodose line). Ideally, it
should be less than 2. Lower homogeneity index
value indicates a more homogeneous target dose.25,26
3) Dose Conformity Index: VR/VT, where VR is the
reference isodose volume (volume of 95% isodose
line in cubic centimetres) and VT is the volume of
the target (in cubic centimetres). Ideally it should
lie between 0.9 and 2.0.27
4) Target Coverage: It is defined in terms of percentage
volume of target covered by prescription isodose
line (95%).
5) Low Isodose Volumes: 10%, 20%, 50% and 70%
isodose volumes (in cubic centimetres) were studied
to compare low dose volumes in IMRT and VMAT.
6) Monitor Units: Number of monitor units required
to deliver daily prescription dose.
7) Treatment Time (beam on to beam off): Time in
minutes (measured by a timer) required to deliver
daily prescription dose including mode up time
between fields (IMRT) and arcs (VMAT).
Results
a) For brain site (Table 4), the OAR dose sparing was
better with IMRT whereas, mean whole brain dose
was lower for VMAT. Figure 1(A and B) shows Dose
Volume Histogram (DVH) showing comparison of
OAR doses and PTV coverage, respectively.
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TABLE 4: Brain OAR doses (cGy) and plan quality parameters [Mean and standard deviation (SD)].
Brain
OAR IMRT (cGy) VMAT (cGy)Mean SD Mean SD
Lens (max dose) 327 194 327.2 158
Retina (max dose) 1397 1268 1395.3 958
Optic nerve (max dose) 2096.5 1808 2189.5 1527
Optic chiasma (max dose) 4396 1278 4570.8 908
Brain stem (max dose) 5530.8 372 5618.6 289
Whole brain (mean dose) 3741.8 738 3720.5 731
DOSE PARAMETERS
Mean body dose 1265.98 205 1258.52 185
PTV max isodose 103.3% 1.14 105.22% 0.56
Homogeneity index 1.052 0.01 1.07 0.007
Conformity index 1.22 0.29 1.034 0.26
Target coverage 99.74% 0.47 99.10% 1.7
Low isodose
Volume(cc)
10% 2012.4 224.9 2123.2 254
20% 1616.4 229.9 1712.4 204
50% 974.4 242 902 249
70% 666.2 204 623.4 180
Monitor units 458 88 354 113
Treatment time (minutes) 2.478 0.11 2.286 0.37
FIG. 1(A): Dose volume histogram of a brain case showing comparison of OAR doses for VMAT and IMRT.
FIG. 1(B): Dose volume histogram of a brain case showing comparison of Body dose and PTV coverage for VMAT and IMRT.
b) For head and neck site (Table 5), OAR dose sparing was better with VMAT. Figure 2(B and C) shows DVH showing
comparison of OAR doses and PTV coverage respectively.
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TABLE 5: Head and neck OAR doses (cGy) and plan quality parameters [Mean and standard deviation (SD)].
Head
and
Neck
OAR IMRT (cGy) VMAT (cGy)Mean SD Mean SD
Parotids (mean dose) 2561.3 385 2178.9 591
Parotids minus PTV (mean dose) 2187 180 1776.2 143
Spinal cord (max dose) 4449.2 125 4185.6 50
Cochlea (mean dose) 1790.6 1527 1670.5 937
Brain stem (max dose) 4944.8 403 4932.8 236
DOSE PARAMETERS
Mean body dose 1477.7 529 1405.34 443
PTV max isodose 106.5% 1.35 105.48% 0.71
Homogeneity index 1.082 0.014 1.072 0.008
Conformity index 1.237 0.37 1.11 0.2
Target coverage
PTV 1 98.24 2.49 97.74 2.72
PTV 2 98.24 2.42 97.06 2.27
PTV 3 97.64 2.46 96.14 3.53
Low isodose volume
(cc)
10% 9065.6 5329 8889 5038
20% 7925.4 5624 7409.4 5439
50% 5093.2 5981 4725.8 5726
70% 3877.8 5805 3834.8 5563
Monitor units 1228 143 465 46
Treatment time (minutes) 7.132 0.79 2.89 0.07
FIG. 2(A): Head and neck plan comparison: IMRT vs VMAT, axial planning CT image with dose in colour wash showing 40 Gy isodose volume.
FIG. 2(B): Dose volume histogram of a head and neck case showing comparison of OAR doses for VMAT and IMRT.
6 Ali et al.: Dosimetric analysis of IMRT and VMAT International Journal of Cancer Therapy and Oncology
www.ijcto.org
© Ali et al. ISSN 2330-4049
FIG. 2(C): Dose volume histogram of a head and neck case showing comparison of Body dose and PTV [PTV 1 (high risk), PTV 2 (inter-
mediate risk) and PTV 3 (low risk)] coverage for VMAT and IMRT.
c) For chest wall site (Table 6), mean ipsilateral lung dose and V10 (Figure 3A) were lower for IMRT whereas, V20 and V40
were lower for VMAT. Mean heart dose and V10 was lower with IMRT whereas, V20 and V40 (Figure 3B) were lower for
VMAT. Opposite breast sparing was better with IMRT. Figure 3C shows DVH showing comparison of OAR doses.
TABLE 6: Chest wall OAR doses (cGy) and plan quality parameters [Mean and standard deviation (SD)].
Chest wall
OAR (cGy) IMRT (cGy) VMAT (cGy)Mean SD Mean SD
Ipsilateral lung
Mean 1416 151 1433 166
V10 33.60% 3.97 47% 8.18
V20 26.60% 3.84 22.80% 3.76
V40 18.20% 3.7 5.80% 2.48
Contralateral lung
(mean dose) 41.6
14.4 443.2 53.5
Heart
Mean 854 455 1119.3 277
V10 18% 10 37.60% 15
V20 15% 9.8 12.60% 7.5
V40 11% 8.7 1.38% 1.4
Contralateral breast
(mean dose) 92.8 22 456.6 96
DOSE PARAMETERS
Mean body dose 593.12 61 724.52 39.9
PTV max isodose 108.9% 1.1 108.66% 0.6
Homogeneity index 1.144 0.008 1.14 0.007
Conformity index 1.628 0.2 1.06 0.1
Monitor units 452 23 592 55
Treatment time (minutes) 4.44 0.5 2.146 0.07
FIG. 3(A): Chest wall plan comparison: IMRT vs VMAT, axial planning CT image with dose in colour wash showing ipsilateral lung V10 (volume
of lung receiving minimum dose of 10 Gy).
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FIG. 3(B): Chest wall plan comparison: IMRT vs VMAT, axial planning CT image with dose in colour wash showing ipsilateral lung V40 (volume
of lung receiving minimum dose of 40 Gy).
FIG. 3(C): Dose volume histogram of a Chest Wall case showing comparison of OAR doses for VMAT and IMRT.
(d) For prostate site (Table 7), rectal sparing was better with VMAT whereas, bladder sparing was better with IMRT. Femoral head
(Figure 4A) and bowel sparing was better with VMAT. Figure 4(B and C) shows DVH showing comparison of OAR doses and
PTV coverage respectively.
FIG. 4(A): Prostate plan comparison: IMRT vs VMAT, axial planning CT image with dose in colour wash showing 30 Gy volume and sparing of
femoral heads.
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FIG. 4(B): Dose volume histogram of a Prostate case showing comparison of OAR doses for VMAT and IMRT.
FIG. 4(C): Dose volume histogram of a Prostate case showing comparison of Body dose and PTV coverage for VMAT and IMRT.
TABLE 7: Prostate OAR doses (cGy) and plan quality parameters [Mean and standard deviation (SD)].
Prostate
OAR (cGy) IMRT (cGy) VMAT (cGy)Mean SD Mean SD
Rectum
Mean 5392.58 397 5297.6 636
V70 26.60% 7.19 24.20% 4.9
V65 34% 7.3 33.20% 6.6
V40 75.20% 10.3 73.80% 18.4
Bladder
Mean 4651.1 372 4818.2 415
V70 17.60% 5.7 18% 6.7
V65 21.60% 6.9 22.60% 8.2
V40 57.40% 9.3 59.60% 6.2
Femoral head Mean 2976.94 426 2213 303V50 1.36% 0.78 0.85% 0.83
Bowel Mean 2142.18 535 2037.4 546V40 16% (249.4cc) 125 14% (219cc) 127
DOSE PARAMETERS
Mean body dose 1286.76 268 1235.4 249
PTV max isodose 104.22% 0.59 104.39% 0.76
Homogeneity index 1.094 0.005 1.09 0.18
Conformity index 1.49 0.18 1.414 0.23
Target coverage 99.92% 0.08 99.92% .08
Low isodose
volume(cc)
10% 11478.2 2559 11921.2 2652
20% 8912.8 1818 8975 2000
50% 2691.8 605 2373 424
70% 761.8 326 702.4 275
Monitor units 1108 135 535 50
Treatment time
(minutes) 8.11
0.5 2.876 0.01
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In summary, the plan quality and treatment efficiency pa-
rameter comparison shows:
a) Mean body doses for brain, head and neck and
prostate were lower with VMAT whereas, for chest
wall cases, mean body dose was lower for IMRT.
b) HI for head and neck, chest wall and prostate was
better with VMAT whereas, it was better with
IMRT for brain.
c) CI was better for all the four sites with VMAT.
d) Target coverage was better with IMRT for brain,
head and neck whereas, it was similar to VMAT for
prostate.
e) Low isodose volumes – V10 and V20 for brain and
prostate were lower for IMRT whereas, V50 and V70
were lower for VMAT. For head and neck, all the
four low isodose volumes (V10, V20, V50 and V70)
were lower for VMAT.
f) MUs required to deliver daily prescription dose for
brain, head and neck and prostate were lower for
VMAT whereas, for chest wall cases MUs required
were lower for IMRT.
g) Treatment time with VMAT was less for all the four
sites studied as compared to IMRT.
Discussion
VMAT (RapidArc) is an advanced radiation treatment mo-
dality. It has a potential to generate treatment plans for var-
ious anatomical sites which are comparable with the corre-
sponding IMRT plans in terms of OAR sparing, plan quality
with better treatment efficiency. In the present study, VMAT
plans were compared with IMRT plans. Various dose-volume
parameters to assess OAR sparing were studied. Plan quality
was assessed by comparing dose HI, CI, target coverage, low
isodose volumes, monitor units and treatment time.
It was observed that for OAR sparing, VMAT is comparable
to IMRT for most of the OARs; however VMAT scored over
IMRT for “parotid minus PTV”, spinal cord and femoral head
sparing. For chest wall cases, IMRT scored over VMAT for
ipsilateral lung V10, contralateral lung mean dose, contrala-
teral breast mean dose and mean body dose, however VMAT
scored over IMRT for ipsilateral lung V40. The possible ex-
planation for high 10 Gy isodose volume for VMAT is that the
chest wall target is treated with a semi arc and the beam is on
throughout the sweep of gantry hence increasing the exit
dose through lung parenchyma. Whereas, since the IMRT
plans for chest wall were all forward IMRT plans with mod-
ulation of intensity in the tangential fields (using sub-fields),
only a small thickness of lung parenchyma was in the field,
hence better V10.
The reason for better V40 for VMAT is that since the dose
distribution was more conformal for VMAT, 40 Gy isodose
line was closer to the target contour, hence minimizing the
volume of lung encompassed. VMAT (Rapid Arc) showed
higher 10% and 20% isodose volumes whereas, IMRT showed
higher 50% and 70% isodose volumes for Brain and Prostate
site. For Head and Neck site, all the isodose levels studied
(10%, 20%, 50% and 70%) were higher for IMRT. Ekam-
baram et al.28 analysed low dose level volumes in IMRT and
3D conformal radiotherapy.
For plan quality parameters, it was observed that VMAT and
IMRT achieved almost similar dose maximum levels inside
the PTV except for brain site, where IMRT scored over
VMAT by achieving a lesser PTV dose maximum. Similarly,
both the plans achieved comparable H.I except for brain site,
where IMRT scored over VMAT because of lesser PTV dose
max. C.I achieved by IMRT and VMAT were similar except
for chest wall cases, where VMAT achieved better dose con-
formity. Target coverage was almost equally good with both
the plans.
The most significant observation of this study was the dif-
ference in MUs and treatment time between the two modali-
ties. VMAT clearly scored over IMRT in terms of MUs re-
quired to deliver daily the prescription dose. VMAT delivers
significantly less MUs per treatment session as compared to
IMRT. Treatment time (including mode up time) was signif-
icantly less with VMAT as compared to IMRT thereby in-
creasing the throughput of the department. These results are
in good agreement with the published literature.
The AAA calculation algorithm improves the accuracy of
dose calculations over pencil beam algorithm and particular
progress has been made with respect to the penumbra and
low dose regions.29However, AAA dose calculation algorithm
has some limitations when there is presence of tissue heter-
ogeneity. In general, AAA over predicts the dose beyond low
density regions and under predicts the dose distal to high
density tissue. In the presence of tissue heterogeneity, there
can be differences of up to 10.2% in lung with AAA calcula-
tion as compared to Monte Carlo calculations.30 More re-
cently, Acuros XB dose calculation algorithm has been in-
troduced the results of which were found to agree better with
Monte Carlo calculations as compared to AAA.30, 31, 32
Conclusion
The dosimetric plan quality parameters of VMAT are com-
parable with IMRT plans. OAR sparing with VMAT is com-
parable with IMRT except for “parotid minus PTV”, spinal
cord and head of femur, where VMAT proved itself better
than IMRT. The most significant differences between VMAT
and IMRT plans were the daily treatment time and monitor
units per treatment session, where VMAT scored over IMRT.
Reducing the daily treatment time decreases the chances of
geographic miss due to organ motion and increases patient
comfort and compliance.
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